01 13F. Hoffmann-La Roche
02 2Genentech
03 1Roche Diagnostics GmbH
01 1Concentrate For Infusion Solution
02 4Concentrate For Solution For Infusion
03 1INF
04 2INJECTABLE;INJECTION
05 1Injectable Solution
06 1SOLUTION
07 2Solution For Injection
08 4Blank
01 2Allowed
02 2Approved
03 1Authorized
04 1Marketed
05 1Not Marketed
06 1Originator
07 1Schedule D
08 7Blank
01 2OCREVUS
02 1OCREVUS ZUNOVO
03 9Ocrevus
04 2Ocrevus SC
05 1Ocrevus subcutaneously
06 1Ocrevus®
01 4Australia
02 1Canada
03 1Moldova
04 2Norway
05 1South Africa
06 1Spain
07 2Sweden
08 2Switzerland
09 2USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ocrevus
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 300mg/10ml
Packaging :
Approval Date : 20/09/2017
Application Number : 66185
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ocrevus subcutaneously
Dosage Form : Solution For Injection
Dosage Strength : 920mg/23ml
Packaging :
Approval Date : 15/11/2024
Application Number : 68988
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ocrevus
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 300mg
Packaging :
Approval Date : 08/01/2018
Application Number : 20160427000077
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ocrevus
Dosage Form : Injectable Solution
Dosage Strength : 920mg
Packaging :
Approval Date : 21/06/2024
Application Number : 20230925000050
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : OCREVUS
Dosage Form : SOLUTION
Dosage Strength : 30MG/ML
Packaging : 15ML VIAL
Approval Date :
Application Number : 2467224
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Ocrevus
Dosage Form : INF
Dosage Strength : 300mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus SC
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus SC
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Moldova
Brand Name : Ocrevus®
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 30mg/ml
Packaging :
Approval Date : 24-06-2023
Application Number :
Regulatory Info :
Registration Country : Moldova
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Ocrevus
Dosage Form : Solution For Injection
Dosage Strength : 920mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Brand Name : Ocrevus
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : OCREVUS
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30MG/1ML
Packaging :
Approval Date :
Application Number : 761053
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
OCRELIZUMAB AND HYALURONIDASE-OCSQ
Brand Name : OCREVUS ZUNOVO
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 40MG;1000UNITS PER ML
Packaging :
Approval Date :
Application Number : 761371
Regulatory Info :
Registration Country : USA
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ocrevus
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 300MG
Packaging :
Approval Date : 2018-02-02
Application Number : 1171231001
Regulatory Info : Authorized
Registration Country : Spain
